BRAF and colorectal carcinoma: There are five key driver genes, APC, TP53, RAS, BRAF, and PIK3CA, that play a critical role in the adenoma–carcinoma sequence of CRC, and the mutational status of these genes can influence the clinical outcome of CRC patients.